Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Avoiding the Risks of Being Wrong in Drug Discovery
Posted on May 5th, 2017 by Christine de Vries - Scheidegger in Pharma R&D
In a recent case study featuring a mid-market biopharma company, a pre-clinical research leader explains that in order to avoid the risks of being wrong when investigating potential new molecules Continue reading “Avoiding the Risks of Being Wrong in Drug Discovery” »